Primary biliary cirrhosis and the nuclear pore complex

Agmon-Levin, 2010, A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis, J Autoimmun, 34, 55, 10.1016/j.jaut.2009.08.009 Aringer, 2012, Therapeutic blockade of TNF in patients with SLE—promising or crazy?, Autoimmun Rev, 11, 321, 10.1016/j.autrev.2011.05.001 Belizna, 2010, Anti-Ku antibodies: clinical, genetic and diagnostic insights, Autoimmun Rev, 9, 691, 10.1016/j.autrev.2010.05.020 Bonaguri, 2011, Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results, Autoimmun Rev, 11, 1, 10.1016/j.autrev.2011.06.006 Defendenti, 2011, Clinical and laboratory aspects of Ro/SSA-52 autoantibodies, Autoimmun Rev, 10, 150, 10.1016/j.autrev.2010.09.005 Lee, 2010, Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes, J Autoimmun, 35, 358, 10.1016/j.jaut.2010.07.007 Perl, 2010, Pathogenic mechanisms in systemic lupus erythematosus, Autoimmunity, 43, 1, 10.3109/08916930903374741 Szalat, 2010, Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: clinical and immunological features: a propos of 40 new cases and review of the literature, Autoimmun Rev, 9, 652, 10.1016/j.autrev.2010.05.001 Tan, 1966, Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus, J Clin Invest, 45, 1732, 10.1172/JCI105479 Ullal, 2011, Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus, J Autoimmun, 36, 173, 10.1016/j.jaut.2011.02.001 Wang, 2011, Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism, J Autoimmun, 37, 18, 10.1016/j.jaut.2011.03.002 Shoenfeld, 2005, Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential, Arthritis Rheum, 52, 2599, 10.1002/art.21252 Meroni, 2008, Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies, Autoimmun Rev, 7, 585, 10.1016/j.autrev.2008.08.001 Forger, 2004, Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis, Lupus, 13, 36, 10.1191/0961203304lu485oa Worman, 2007, Nuclear envelope protein autoantigens in primary biliary cirrhosis, Hepatol Res, 37, S406, 10.1111/j.1872-034X.2007.00227.x Bogdanos, 2008, Autoimmune liver serology: current diagnostic and clinical challenges, World J Gastroenterol, 14, 3374, 10.3748/wjg.14.3374 Bogdanos, 2011, Disease-specific autoantibodies in primary biliary cirrhosis, Clin Chim Acta, 412, 502, 10.1016/j.cca.2010.12.019 Courvalin, 1997, Nuclear envelope protein autoantibodies in primary biliary cirrhosis, Semin Liver Dis, 17, 79, 10.1055/s-2007-1007185 Worman, 2003, Antinuclear antibodies specific for primary biliary cirrhosis, Autoimmun Rev, 2, 211, 10.1016/S1568-9972(03)00013-2 Ruffatti, 1985, Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis, J Clin Immunol, 5, 357, 10.1007/BF00918255 Lassoued, 1990, Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis, Gastroenterology, 99, 181, 10.1016/0016-5085(90)91246-3 Lassoued, 1988, Antinuclear autoantibodies specific for lamins. Characterization and clinical significance, Ann Intern Med, 108, 829, 10.7326/0003-4819-108-6-829 Lozano, 1988, Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis, Hepatology, 8, 930, 10.1002/hep.1840080438 Courvalin, 1990, Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis, J Exp Med, 172, 961, 10.1084/jem.172.3.961 Miyachi, 2003, Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study, J Autoimmun, 20, 247, 10.1016/S0896-8411(03)00033-7 Kraemer, 2003, Nucleoporin p62 antibodies in a case of mixed connective tissue disease, Clin Diagn Lab Immunol, 10, 329, 10.1128/CDLI.10.2.329-331.2003 Kraemer, 2010, Nuclear pore protein p62 autoantibodies in systemic lupus erythematosus, Open Rheumatol J, 4, 24, 10.2174/1874312901004010024 Hetzer, 2010, The nuclear envelope, Cold Spring Harb Perspect Biol, 2, a000539, 10.1101/cshperspect.a000539 Hoelz, 2011, The structure of the nuclear pore complex, Annu Rev Biochem, 80, 613, 10.1146/annurev-biochem-060109-151030 Macara, 2001, Transport into and out of the nucleus, Microbiol Mol Biol Rev, 65, 570, 10.1128/MMBR.65.4.570-594.2001 Hsia, 2007, Architecture of a coat for the nuclear pore membrane, Cell, 131, 1313, 10.1016/j.cell.2007.11.038 Alber, 2007, The molecular architecture of the nuclear pore complex, Nature, 450, 695, 10.1038/nature06405 Alber, 2007, Determining the architectures of macromolecular assemblies, Nature, 450, 683, 10.1038/nature06404 Callan, 1950, Experimental studies on amphibian oocyte nuclei. I. Investigation of the structure of the nuclear membrane by means of the electron microscope, Proc R Soc Lond B Biol Sci, 137, 367, 10.1098/rspb.1950.0047 Watson, 1959, Further observations on the nuclear envelope of the animal cell, J Biophys Biochem Cytol, 6, 147, 10.1083/jcb.6.2.147 Rout, 1993, Isolation of the yeast nuclear pore complex, J Cell Biol, 123, 771, 10.1083/jcb.123.4.771 Matunis, 1996, A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex, J Cell Biol, 135, 1457, 10.1083/jcb.135.6.1457 Davis, 1986, Identification and characterization of a nuclear pore complex protein, Cell, 45, 699, 10.1016/0092-8674(86)90784-1 DeGrasse, 2009, Evidence for a shared nuclear pore complex architecture that is conserved from the last common eukaryotic ancestor, Mol Cell Proteomics, 8, 2119, 10.1074/mcp.M900038-MCP200 Courvalin, 1990, The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore, J Clin Invest, 86, 279, 10.1172/JCI114696 Nickowitz, 1994, Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis, Gastroenterology, 106, 193, 10.1016/S0016-5085(94)95333-3 Wozniak, 1989, Primary structure analysis of an integral membrane glycoprotein of the nuclear pore, J Cell Biol, 108, 2083, 10.1083/jcb.108.6.2083 Greber, 1990, A major glycoprotein of the nuclear pore complex is a membrane-spanning polypeptide with a large lumenal domain and a small cytoplasmic tail, EMBO J, 9, 1495, 10.1002/j.1460-2075.1990.tb08267.x Favreau, 2001, Biochemical characterization of nuclear pore complex protein gp210 oligomers, Eur J Biochem, 268, 3883, 10.1046/j.1432-1327.2001.02290.x Nickowitz, 1993, Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210, J Exp Med, 178, 2237, 10.1084/jem.178.6.2237 Wesierska-Gadek, 1995, Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210, J Exp Med, 182, 1159, 10.1084/jem.182.4.1159 Bandin, 1996, Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis, Hepatology, 23, 1020, 10.1002/hep.510230512 Itoh, 1998, Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis, J Gastroenterol Hepatol, 13, 257, 10.1111/j.1440-1746.1998.01553.x Tartakovsky, 1995, Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope, Hepatology, 21, 495 Mattalia, 1997, Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis, J Autoimmun, 10, 491, 10.1006/jaut.1997.0156 Miyachi, 1996, Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC, Mol Biol Rep, 23, 227, 10.1007/BF00351173 Luettig, 1998, The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis, J Hepatol, 28, 824, 10.1016/S0168-8278(98)80233-X Nakamura, 2007, Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis, Hepatology, 45, 118, 10.1002/hep.21472 Nakamura, 2005, Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis, J Hepatol, 42, 386, 10.1016/j.jhep.2004.11.016 Liu, 2010, PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis, J Autoimmun, 35, 436, 10.1016/j.jaut.2010.09.005 Muratori, 2003, Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis, Am J Gastroenterol, 98, 431, 10.1111/j.1572-0241.2003.07257.x Schwarz-Herion, 2007, Domain topology of the p62 complex within the 3-D architecture of the nuclear pore complex, J Mol Biol, 370, 796, 10.1016/j.jmb.2007.05.030 Guan, 1995, Structural analysis of the p62 complex, an assembly of O-linked glycoproteins that localizes near the central gated channel of the nuclear pore complex, Mol Biol Cell, 6, 1591, 10.1091/mbc.6.11.1591 Capelson, 2010, Nuclear pore complexes: guardians of the nuclear genome, Cold Spring Harb Symp Quant Biol, 75, 585, 10.1101/sqb.2010.75.059 Wesierska-Gadek, 1996, Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis, Gastroenterology, 110, 840, 10.1053/gast.1996.v110.pm8608894 Wesierska-Gadek, 2007, Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies, Ann N Y Acad Sci, 1109, 519, 10.1196/annals.1398.058 Wesierska-Gadek, 2008, Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen, J Cell Biochem, 104, 27, 10.1002/jcb.21595 Ou, 2004, The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence, Clin Exp Immunol, 136, 379, 10.1111/j.1365-2249.2004.02432.x Wesierska-Gadek, 2006, Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis, Hepatology, 43, 1135, 10.1002/hep.21172 Meda, 2009, Fine specificity of anti-nup62 T-helper 1 cell (TH1) immune responses in priumary biliary cirrhosis, J Hepatol, 50, S248, 10.1016/S0168-8278(09)60678-4 Invernizzi, 2001, Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis, J Hepatol, 34, 366, 10.1016/S0168-8278(00)00040-4 Bogdanos, 2007, Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis, Hepatology, 45, 1583, 10.1002/hep.21678 Sfakianaki, 2010, Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients, World J Gastroenterol, 16, 4938, 10.3748/wjg.v16.i39.4938 Nakamura, 2006, Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis, J Autoimmun, 26, 138, 10.1016/j.jaut.2005.10.007 Kaplan, 2005, Primary biliary cirrhosis, N Engl J Med, 353, 1261, 10.1056/NEJMra043898 Neuberger, 1997, Primary biliary cirrhosis, Lancet, 350, 875, 10.1016/S0140-6736(97)05419-6 Neuberger, 2003, Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence, J Hepatol, 39, 142, 10.1016/S0168-8278(03)00283-6 Neuberger, 2003, Liver transplantation for primary biliary cirrhosis, Autoimmun Rev, 2, 1, 10.1016/S1568-9972(02)00103-9 Dubel, 1998, Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation, J Hepatol, 28, 169, 10.1016/S0168-8278(98)80220-1 Shimoda, 2003, Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis, Gastroenterology, 124, 1915, 10.1016/S0016-5085(03)00387-1